Richard G. A. Feachem
Directeur/Membre du Conseil chez VitalConnect, Inc.
Profil
Richard G.
A.
Feachem is currently the Director-meritus at the International AIDS Vaccine Initiative, Inc., a Director at VitalConnect, Inc., and a Professor at the University of California, Berkeley.
He previously served as the Executive Director at The Global Fund to Fight AIDS, Tuberculosis & Malaria.
Postes actifs de Richard G. A. Feachem
| Sociétés | Poste | Début |
|---|---|---|
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Corporate Officer/Principal | 30/11/2010 |
| University of California, Berkeley | Corporate Officer/Principal | - |
VitalConnect, Inc.
 VitalConnect, Inc. Medical SpecialtiesHealth Technology VitalConnect, Inc. operates as a healthcare technology company. The firm offers VitalPatch and Predictive Analytics solutions. It serves to the hospital monitoring, post-discharge, remote patient monitoring and clinical trial markets. The company was founded by Stephen Zadig and Nersi H. Nazari in January 2011 and is headquartered in San Jose, CA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Richard G. A. Feachem
| Sociétés | Poste | Fin |
|---|---|---|
| The Global Fund to Fight AIDS, Tuberculosis & Malaria | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
| The Global Fund to Fight AIDS, Tuberculosis & Malaria | Commercial Services |
VitalConnect, Inc.
VitalConnect, Inc. Medical SpecialtiesHealth Technology VitalConnect, Inc. operates as a healthcare technology company. The firm offers VitalPatch and Predictive Analytics solutions. It serves to the hospital monitoring, post-discharge, remote patient monitoring and clinical trial markets. The company was founded by Stephen Zadig and Nersi H. Nazari in January 2011 and is headquartered in San Jose, CA. | Health Technology |